Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney

作者: Fiona E. Karet , Rhoda E. Kuc , Anthony P. Davenport

DOI: 10.1038/KI.1993.210

关键词:

摘要: Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ET A B in human kidney. Endothelins (ET), a group of vasoconstrictor peptides, are expressed wide range tissues species bind to specific receptors which there at least two subtypes, . The kidney has been found animal studies be highly sensitive the effects ET. We have used new peptide ligands, selective for particular (the antagonist agonist ) binding renal receptors. Saturation gave equilibrium dissociation constants (K d [I 125 ]ET-1 0.17 ± 0.04 nM ]BQ3020 0.36 0.06 nM. Hill coefficients were 0.86 0.03 0.77 0.04, respectively. Macro- microautoradiography using ]-labeled with as competing blockers showed majority medulla concentration vasa recta bundles, localizing vascular smooth muscle. subtype predominated over by about 2:1, was more generally distributed, collecting system. These findings confirmed competition assays giving max values (ET /ET , fmol/mg protein), cortex, respectively, 18.7 2.2/11.3 2.7 12.7 3.9/7.6 3.5 BQ3020; 36.2 5.6/11.1 4.1 14.9 1.6/5.3 0.2 BQ123. This study establishes distribution demonstrates that novel thousand-fold selectivities - -receptor results show that, contrast other such heart, contains predominantly subtype.

参考文章(26)
M. L. Zeidel, H. R. Brady, B. C. Kone, S. R. Gullans, B. M. Brenner, Endothelin, a peptide inhibitor of Na(+)-K(+)-ATPase in intact renaltubular epithelial cells. American Journal of Physiology-cell Physiology. ,vol. 257, ,(1989) , 10.1152/AJPCELL.1989.257.6.C1101
G.A McPherson, A practical computer-based approach to the analysis of radioligand binding experiments Computer Programs in Biomedicine. ,vol. 17, pp. 107- 113 ,(1983) , 10.1016/0010-468X(83)90031-4
A. Inoue, M. Yanagisawa, S. Kimura, Y. Kasuya, T. Miyauchi, K. Goto, T. Masaki, The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 86, pp. 2863- 2867 ,(1989) , 10.1073/PNAS.86.8.2863
P Nambi, M Pullen, H L Wu, N Aiyar, E H Ohlstein, R M Edwards, Identification of endothelin receptor subtypes in human renal cortex and medulla using subtype-selective ligands. Endocrinology. ,vol. 131, pp. 1081- 1086 ,(1992) , 10.1210/ENDO.131.3.1324149
Peter Molenaar, Rhoda E. Kuc, Anthony P. Davenport, Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart British Journal of Pharmacology. ,vol. 107, pp. 637- 639 ,(1992) , 10.1111/J.1476-5381.1992.TB14498.X
Valentina Kon, Kamal F. Badr, Biological actions and pathophysiologic significance of endothelin in the kidney Kidney International. ,vol. 40, pp. 1- 12 ,(1991) , 10.1038/KI.1991.172
Peter J Munson, David Rodbard, None, Ligand: a versatile computerized approach for characterization of ligand-binding systems. Analytical Biochemistry. ,vol. 107, pp. 220- 239 ,(1980) , 10.1016/0003-2697(80)90515-1
Christian Waeber, Daniel Hoyer, José-Maria Palacios, Similar distribution of [125I]sarafotoxin-6b and [125I]endothelin-1, -2, -3 binding sites in the human kidney. European Journal of Pharmacology. ,vol. 176, pp. 233- 236 ,(1990) , 10.1016/0014-2999(90)90534-D
Anthony P. Davenport, Derek J. Nunez, James A. Hall, Alberto J. Kaumann, Morris J. Brown, Autoradiographical localization of binding sites for porcine [125I]endothelin-1 in humans, pigs, and rats: functional relevance in humans. Journal of Cardiovascular Pharmacology. ,vol. 13, ,(1989) , 10.1097/00005344-198900135-00045